跳至主要内容
临床试验/NCT01612065
NCT01612065已完成3 期

The Optimum Dose of Vaginal Misoprostol Prior to Office Hysteroscopy: Double Blind Randomized Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2012年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
132
试验地点
1
主要终点
Pain score

研究概览

简要总结

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.

详细描述

The investigators will compare between 2 different doses of vaginal misoprostol, group (1) 200 ug, group (2) 400 ug, 3hours prior to office hysteroscopy , Infertile patient, patients with abnormal bleeding and patient with recurrent abortion Outcome measure: pain score, easiness of the procedure, procedure time, complications

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patient pre- or postmenopausal undergo office hysteroscopy.
  • Age: from 20 to
  • BMI between 18 and 30.

排除标准

  • Heavy uterine bleeding
  • Cervical malignancy.
  • Symptoms suggestive of endometriosis .
  • Any cervical abnormality such as pinhole cervix that would obviate passage of a catheter through the cervix.

研究组 & 干预措施

Misoprostol vaginally, 200 ug

Active Comparator

200 ug misoprostol in the posterior vaginal fornix

干预措施: Misoprostol (Drug)

Misoprostol vaginally, 400ug

Active Comparator

Misoprostol in the posterior vaginal fornix

干预措施: Misoprostol (Drug)

结局指标

主要结局

Pain score

时间窗: 1year

Pain score by VAS

次要结局

  • Easiness(1year)
  • Duration of the procedure(1year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Waleed El-khayat

Assistant professor of obstetrics and gynecology

Cairo University

研究点 (1)

Loading locations...

相似试验